• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

How large does a compound screening collection need to be?

作者信息

Lipkin Michael J, Stevens Adrian P, Livingstone David J, Harris C John

机构信息

BioFocus DPI, Chesterford Research Park, Saffron Walden, Essex, UK.

出版信息

Comb Chem High Throughput Screen. 2008 Jul;11(6):482-93. doi: 10.2174/138620708784911492.

DOI:10.2174/138620708784911492
PMID:18673276
Abstract

Increasingly, chemical libraries are being produced which are focused on a biological target or group of related targets, rather than simply being constructed in a combinatorial fashion. A screening collection compiled from such libraries will contain multiple analogues of a number of discrete series of compounds. The question arises as to how many analogues are necessary to represent each series in order to ensure that an active series will be identified. Based on a simple probabilistic argument and supported by in-house screening data, guidelines are given for the number of compounds necessary to achieve a "hit", or series of hits, at various levels of certainty. Obtaining more than one hit from the same series is useful since this gives early acquisition of SAR (structure-activity relationship) and confirms a hit is not a singleton. We show that screening collections composed of only small numbers of analogues of each series are sub-optimal for SAR acquisition. Based on these studies, we recommend a minimum series size of about 200 compounds. This gives a high probability of confirmatory SAR (i.e. at least two hits from the same series). More substantial early SAR (at least 5 hits from the same series) can be gained by using series of about 650 compounds each. With this level of information being generated, more accurate assessment of the likely success of the series in hit-to-lead and later stage development becomes possible.

摘要

相似文献

1
How large does a compound screening collection need to be?
Comb Chem High Throughput Screen. 2008 Jul;11(6):482-93. doi: 10.2174/138620708784911492.
2
A kinase-focused compound collection: compilation and screening strategy.一个聚焦激酶的化合物库:汇编与筛选策略。
Chem Biol Drug Des. 2006 Jun;67(6):385-94. doi: 10.1111/j.1747-0285.2006.00396.x.
3
Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.基于经验性高通量筛选数据的基于板的多样性选择,以增加命中数及其化学多样性。
J Biomol Screen. 2009 Jul;14(6):690-9. doi: 10.1177/1087057109335678. Epub 2009 Jun 16.
4
Extraction of structure-activity relationship information from high-throughput screening data.从高通量筛选数据中提取结构-活性关系信息。
Curr Med Chem. 2009;16(31):4049-57. doi: 10.2174/092986709789378189.
5
Rationalizing the role of SAR tolerance for ligand-based virtual screening.合理化基于配体的虚拟筛选中 SAR 耐受性的作用。
J Chem Inf Model. 2011 Apr 25;51(4):837-42. doi: 10.1021/ci200064c. Epub 2011 Mar 25.
6
The design of screening libraries targeted at G-protein coupled receptors.
Curr Top Med Chem. 2004;4(6):581-8. doi: 10.2174/1568026043451140.
7
Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.用于药物筛选的市售化合物库的类药性和疏水性增加。
Curr Top Med Chem. 2012;12(14):1500-13. doi: 10.2174/156802612802652466.
8
Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.早期药物发现:化学信息学和计算技术在鉴定先导化合物系列中的应用。
Bioorg Med Chem. 2012 Sep 15;20(18):5324-42. doi: 10.1016/j.bmc.2012.04.062. Epub 2012 May 5.
9
Lead generation--enhancing the success of drug discovery by investing in the hit to lead process.潜在客户生成——通过投资从活性化合物到先导化合物的过程来提高药物发现的成功率。
Comb Chem High Throughput Screen. 2003 Feb;6(1):51-66. doi: 10.2174/1386207033329823.
10
Design of small molecule libraries for NMR screening and other applications in drug discovery.用于核磁共振筛选及药物发现中其他应用的小分子文库设计。
Curr Top Med Chem. 2003;3(1):11-23. doi: 10.2174/1568026033392606.

引用本文的文献

1
Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening.通过高通量筛选发现新型OXA-48β-内酰胺酶抑制剂化学系列
Pharmaceuticals (Basel). 2021 Jun 25;14(7):612. doi: 10.3390/ph14070612.
2
Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.用于高通量筛选中化合物库设计、命中筛选和生物活性建模的数据驱动方法。
Brief Bioinform. 2018 Mar 1;19(2):277-285. doi: 10.1093/bib/bbw105.
3
Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds.
药物再利用:从原生动物蛋白质组中挖掘已知生物活性化合物的作用靶点。
J Am Med Inform Assoc. 2014 Mar-Apr;21(2):238-44. doi: 10.1136/amiajnl-2013-001700. Epub 2013 Jun 11.
4
From laptop to benchtop to bedside: structure-based drug design on protein targets.从笔记本电脑到台式机再到床边:基于结构的药物设计针对蛋白质靶标。
Curr Pharm Des. 2012;18(9):1217-39. doi: 10.2174/138161212799436386.
5
The design and application of target-focused compound libraries.靶向化合物库的设计与应用。
Comb Chem High Throughput Screen. 2011 Jul;14(6):521-31. doi: 10.2174/138620711795767802.
6
Rational methods for the selection of diverse screening compounds.合理的多样性筛选化合物的选择方法。
ACS Chem Biol. 2011 Mar 18;6(3):208-17. doi: 10.1021/cb100420r. Epub 2011 Feb 15.
7
Herman Skolnik award symposium honoring Yvonne Martin.表彰伊冯·马丁的赫尔曼·斯科尔尼茨克奖研讨会。
J Comput Aided Mol Des. 2009 Dec;23(12):831-6. doi: 10.1007/s10822-009-9310-3. Epub 2009 Dec 10.